Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 91,298	$ 84,386
Restricted cash	86	228
Short-term investments	547,353	829,896
Accounts receivable, net of allowance of $3,561 in 2022 and $2,429 in 2021	208,312	122,074
Inventory	30,465	26,909
Prepaid expenses and other current assets, net	24,041	29,645
Total current assets	901,555	1,093,138
Property and equipment, net	81,772	65,516
Operating lease right-of-use assets	62,147	59,013
Other assets	21,502	18,820
Total assets	1,066,976	1,236,487
Current liabilities:
Accounts payable	28,192	27,206
Accrued compensation	32,959	40,941
Other accrued liabilities	124,372	93,353
Deferred revenue, current portion	16,009	7,404
Short-term debt financing	50,086	50,052
Total current liabilities	251,618	218,956
Long-term debt financing	281,020	280,394
Deferred revenue, long-term portion	20,721	21,318
Operating lease liabilities, long-term portion	65,417	61,036
Other long-term liabilities	3,618	1,479
Total liabilities	622,394	583,183
Commitments and contingencies (Note 8)
Stockholders' equity:
Common stock, $0.0001 par value: 750,000 shares authorized at both June 30, 2022 and December 31, 2021, respectively; 96,903 and 95,140 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	10	10
Additional paid in capital	2,139,551	2,050,417
Accumulated deficit	(1,678,582)	(1,394,836)
Accumulated other comprehensive loss	(16,397)	(2,287)
Total stockholders' equity	444,582	653,304
Total liabilities and stockholders' equity	$ 1,066,976	$ 1,236,487